Medpace Holdings Inc (NASDAQ:MEDP) price target raised to $49.00 by Credit Suisse Group

ME Staff
-
0

Analyst Ratings For Medpace Holdings Inc (NASDAQ:MEDP)

Today, Credit Suisse Group raised its price target on Medpace Holdings Inc (NASDAQ:MEDP) to $49.00 per share.

There are 6 Hold Ratings, 2 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Medpace Holdings Inc (NASDAQ:MEDP) is Hold with a consensus target price of $38.80 per share, a potential 38.29% downside.

Some recent analyst ratings include

  • 7/31/2018-William Blair Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
  • 4/20/2018-Mitsubishi UFJ Financial Group Reiterated Rating of Neutral.
  • 3/1/2018-Jefferies Financial Group Reiterated Rating of Hold.
  • 10/17/2017-KeyCorp Reiterated Rating of Hold.

Recent Insider Trading Activity For Medpace Holdings Inc (NASDAQ:MEDP)
Medpace Holdings Inc (NASDAQ:MEDP) has insider ownership of 29.50% and institutional ownership of 27.45%.

  • On 6/14/2018 Medpace Limited Partnership, Major Shareholder, sold 3,000,000 with an average share price of $41.80 per share and the total transaction amounting to $125,400,000.00.
  • On 5/7/2018 Medpace Limited Partnership, Major Shareholder, sold 3,000,000 with an average share price of $35.49 per share and the total transaction amounting to $106,470,000.00.
  • On 12/5/2017 Medpace Limited Partnership, Major Shareholder, sold 4,600,000 with an average share price of $30.16 per share and the total transaction amounting to $138,736,000.00.
  • On 8/22/2017 Medpace Limited Partnership, Major Shareholder, sold 2,000,000 with an average share price of $30.27 per share and the total transaction amounting to $60,540,000.00.
  • On 8/18/2016 August J Troendle, CEO, bought 10,000 with an average share price of $27.98 per share and the total transaction amounting to $279,800.00.
  • On 8/17/2016 Susan E Burwig, Insider, bought 19,211 with an average share price of $29.21 per share and the total transaction amounting to $561,153.31.
  • On 8/16/2016 August J Troendle, CEO, bought 869,565 with an average share price of $23.00 per share and the total transaction amounting to $19,999,995.00.

About Medpace Holdings Inc (NASDAQ:MEDP)
Medpace Holdings, Inc., a clinical contract research organization, provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries worldwide. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in a range of therapeutic areas. Its clinical development services include medical affairs, clinical trial management, feasibility and start-up study, clinical monitoring, global regulatory affairs, medical writing, biometrics, pharmacovigilance, core laboratory, and quality assurance. Medpace Holdings, Inc. was founded in 1992 and is headquartered in Cincinnati, Ohio.

Recent Trading Activity for Medpace Holdings Inc (NASDAQ:MEDP)
Shares of Medpace Holdings Inc closed the previous trading session at 62,76 up +15,69 33,33 % with 63.97 shares trading hands.